Description
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
| Purity | ≥95% |
|---|---|
| Formula | C138H230N46O34S4 |
| Formula Wt. | 3205.89 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hongbiao W, Baolong N, Mengkui X, et al. Biological activities of cecropin B-thanatin hybrid peptides. J Pept Res. 2005 Dec;66(6):382-6. PMID: 16316454.
Effective against gram-positive pathogens
ERK2 inhibitor, potential AurKA, GSK3, CDK2, FL...
Phytoestrogen, flavonoid found in clover, soy, ...
NS3/4A serine protease inhibitor.
Endogenous peptide fragment, involved in vasoco...
Curcumin derivative; DNMT1 and α-amylase inhib...
Optically active cysteine derivative found in A...
Raf inhibitor.
Regioisomers
Serine protease substrate/inhibitor.
DNMT inhibitor.
Macrolide antibiotic; peptidyl transferase inhi...
Macrocyclic lactone.
Semi-synthetic avermectin; GABA potentiator.
Penciclovir prodrug, nucleoside (guanosine) ana...
1-Naphthalenacetic acid derivative, NSAID; COX-...
Precursor in the synthesis of hydroquinone, ant...
Prolyl hydroxylase inhibitor.
Peptide, derivative of AT II, involved in vasoc...
IGF-1R inhibitor.